Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance.
Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance.
复制标题
DOI：
10.1186/s12968-023-00933-0
复制
发表时间：
2023-03-27
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
2019 年冠状病毒病 (COVID-19) 是一种持续的全球大流行病，迄今为止已影响全球近 6 亿人。虽然 COVID-19 主要是一种呼吸系统疾病，但已知也会发生心脏损伤。心血管磁共振 (CMR) 成像具有独特的能力，能够表征体内心肌组织特性，从而能够深入了解心脏损伤的模式和程度。据报告，在既往住院患者中，CMR 确定的 COVID-19 感染心肌受累患病率范围为 26% 至 60%。报告的心肌受累患病率的差异可能是由于不同的患者群体（例如疾病严重程度的差异）以及急性感染和 CMR 评估之间的时间间隔不同造成的。图像采集、分析、解释和报告 CMR 异常的标准化方法可能会提高研究之间的一致性。心血管磁共振协会 (SCMR) 的这份共识文件提供了有关 CMR 成像和报告指标的建议，以期在对 COVID-19 感染患者进行 CMR 时改进标准化、统一数据采集和分析方法。在线版本包含可在 10.1186/s12968-023-00933-0 获取的补充材料。
Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection. The online version contains supplementary material available at 10.1186/s12968-023-00933-0.
登录
查看更多内容
DOI：
10.1186/s12968-021-00801-9
发表时间：
2021-11-04
期刊：
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
影响因子：
--
作者：
Uretsky S;Aggarwal N;van Heeswijk RB;Rajpal S;Rowin E;Taylor MD;Verjans JW;Wokhlu A;Markl M;Raman SV;Shah DJ
通讯作者：
Shah DJ
DOI：
10.1186/s12968-015-0182-5
发表时间：
2015-08-28
期刊：
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
影响因子：
--
作者：
Ferreira VM;Wijesurendra RS;Liu A;Greiser A;Casadei B;Robson MD;Neubauer S;Piechnik SK
通讯作者：
Piechnik SK
影响因子：
37.8
作者：
Bozkurt, Biykem;Kamat, Ishan;Hotez, Peter J.
通讯作者：
Hotez, Peter J.
DOI：
10.1007/s00392-021-01929-5
发表时间：
2021-11
期刊：
Clinical research in cardiology : official journal of the German Cardiac Society
影响因子：
--
作者：
Breitbart P;Koch A;Schmidt M;Magedanz A;Lindhoff-Last E;Voigtländer T;Schmermund A;Mehta RH;Eggebrecht H
通讯作者：
Eggebrecht H
DOI：
10.1016/j.jcmg.2020.10.023
发表时间：
2021-03
期刊：
JACC. Cardiovascular imaging
影响因子：
--
作者：
Brito D;Meester S;Yanamala N;Patel HB;Balcik BJ;Casaclang-Verzosa G;Seetharam K;Riveros D;Beto RJ 2nd;Balla S;Monseau AJ;Sengupta PP
通讯作者：
Sengupta PP